Steffen Meyer

Steffen Meyer has a diverse work experience in the biotechnology and research industry. Steffen started their career as a Trainee at Glycotope GmbH in 2008. Steffen then worked at the Helmholtz Centre for Infection Research as a PhD Student from October 2008 to April 2012, and later as a Postdoctoral Researcher from May 2012 to May 2013.

In 2013, Steffen joined ImmunoQure AG as a Research Scientist in Molecular Biology and Protein Sciences. In this role, they led a team of research assistants in discovering patient-selected antibodies for the treatment of inflammatory and autoimmune diseases. Steffen was responsible for cloning monoclonal antibodies, recombinant expression, purification, and biophysical characterization. Additionally, they coordinated international and interdisciplinary collaborations with academic partners and contract manufacturing organizations. Steffen also served as the Biosafety Officer.

Since 2015, Steffen has been working at ethris GmbH. Steffen started as a Group Leader in Antibody Technology and held this position until January 2019. From February to December 2019, they served as the Director of Discovery Biology - Group Leader Protein Science and Analytics. In 2020, they were a Director at ethris GmbH. Currently, they hold the role of Senior Director, starting from January 2021.

Overall, Steffen Meyer has held various scientific and leadership roles throughout their career, showcasing their expertise in protein science, antibody technology, and research management.

Steffen Meyer attended the Technische Universität Braunschweig from 2002 to 2007, where they obtained a Diploma in Biotechnology. In addition, in March 2014, they obtained the certification for Permission to act as a project leader according to German regulations for biosafety and genetic engineering (Projektleiterkurs nach §15 GenTSV). There is no information provided about the institution where this certification was obtained.